Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs051190013Completed
Trial in chronic kidney disease (CKD) and hyperphosphatemia (2 arms), sponsored by Kissei Pharmaceutical Co., Ltd. Primary endpoint: Adverse events and survival. Started May 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs051190013.